Exhibit 1.1
EXECUTION
COPY
7,425,743 Shares
Dyax Corp.
Common Stock
($0.01 Par Value)
UNDERWRITING
AGREEMENT
June 24, 2009
Deutsche Bank Securities
Inc.
60 Wall Street, 4
th Floor
New York, New York
10005
Ladies and Gentlemen:
Dyax Corp., a Delaware corporation
(the “ Company ”), proposes to sell to Deutsche
Bank Securities Inc. (the “ Underwriter ”) an
aggregate of 7,425,743 shares (the “ Firm Shares
”) of the Company’s common stock, $0.01 par value (the
“ Common Stock ”). The Company also
proposes to sell at the Underwriter’s option an aggregate of
up to 1,113,862 additional shares of Common Stock (the “
Option Shares ”) as set forth below.
As the Underwriter, you have advised
the Company that you are willing to purchase the Firm Shares, plus
the Option Shares if you elect to exercise the over-allotment
option in whole or in part. The Firm Shares and the Option
Shares (to the extent the aforementioned option is exercised) are
herein collectively called the “ Shares
.”
In consideration of the mutual
agreements contained herein and of the interests of the parties in
the transactions contemplated hereby, the parties hereto agree as
follows:
1.
Representations and Warranties of
the Company .
The Company represents and warrants
to the Underwriter as follows:
(a)
A “shelf” registration
statement on Form S-3 (File No. 333-148317) with respect
to the Common Stock of the Company has been prepared by the Company
in conformity with the requirements of the Securities Act of 1933,
as amended (the “ Act ”), and the rules and
regulations (the “ Rules and Regulations ”)
of the Securities and Exchange Commission (the “
Commission ”) thereunder and has been filed with the
Commission. The Company and the transactions contemplated by
this Agreement meet the requirements and comply with the
conditions for the use of Form S-3.
The Registration Statement meets the requirements of
Rule 415(a)(1)(x) under the Act and complies in all
materials respects with said rule. Copies of such
registration statement, including any amendments thereto, the
preliminary base prospectus (meeting the requirements of the
Rules and Regulations) contained therein and the exhibits,
financial statements and schedules, as finally amended and revised,
have heretofore been delivered by the Company to the
Underwriter. Such registration statement, together with any
registration statement filed by the Company pursuant to
Rule 462(b) under the Act, is herein referred to as the
“ Registration Statement ,” which shall be
deemed to include all information omitted therefrom in reliance
upon Rules 430A, 430B or 430C under the Act and contained in
the Prospectus referred to below, has become effective under the
Act and no post-effective amendment to the Registration Statement
(except to the extent that the Company’s filing of its
Form 10-K on March 4, 2009 constitutes such a
post-effective amendment) has been filed as of the date of this
Agreement. “ Prospectus ” means the form
of base prospectus and final prospectus supplement first filed with
the Commission pursuant to and within the time limits described in
Rule 424(b) under the Act. Any preliminary
prospectus relating to the Shares prior to the date hereof is
herein referred to as a “ Preliminary Prospectus
.” Any reference herein to the Registration Statement,
any Preliminary Prospectus or to the Prospectus or to any amendment
or supplement to any of the foregoing documents shall be deemed to
refer to and include any documents incorporated by reference
therein, and, in the case of any reference herein to the
Prospectus, also shall be deemed to include any documents
incorporated by reference therein, and any supplements or
amendments thereto, filed with the Commission after the date of
filing of the Prospectus under Rule 424(b) under the Act,
and prior to the termination of the offering of the Shares by the
Underwriter.
(b)
As of the Applicable Time and as of
the Closing Date and the Option Closing Date, as the case may be,
neither the Preliminary Prospectus nor any Issuer Free Writing
Prospectus(es) (as defined below) and the information included on
Schedule I hereto, all considered together (collectively,
the “ General Disclosure Package ”), included or
will include any untrue statement of a material fact or omitted or
will omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading; provided, however, that the Company
makes no representations or warranties as to information contained
in or omitted from any Issuer Free Writing Prospectus, in reliance
upon, and in conformity with, written information furnished to the
Company by the Underwriter, specifically for use therein, it being
understood and agreed that the only such information is that
described in Section 12 herein. As used in this
Section 1(b) and elsewhere in this
Agreement:
“ Applicable Time
” means 7:00 p.m. (New York time) on the date of this
Agreement or such other time as agreed to in writing by the Company
and the Underwriter.
“ Issuer Free Writing
Prospectus ” means any “issuer free writing
prospectus,” as defined in Rule 433 under the Act,
relating to the Shares in the form filed or required to be filed
with the Commission or, if not required to be filed, in the form
retained in the Company’s records pursuant to
Rule 433(g) under the Act.
(c)
The Commission has not issued an
order preventing or suspending the use of any Preliminary
Prospectus, any Issuer Free Writing Prospectus or the Prospectus
relating to
2
the proposed offering of the Shares, and no
proceeding for that purpose or pursuant to Section 8A of the
Act has been instituted or, to the Company’s knowledge,
threatened by the Commission. The Registration Statement contains,
and the Prospectus and any amendments or supplements thereto will
contain, all statements which are required to be stated therein by,
and will conform to, the requirements of the Act and the
Rules and Regulations. The documents incorporated, or to
be incorporated, by reference in the Prospectus, at the time filed
with the Commission conformed or will conform, in all respects to
the requirements of the Securities Exchange Act of 1934, as amended
(“ Exchange Act ”), or the Act, as applicable,
and the rules and regulations of the Commission
thereunder. The Registration Statement and any amendment
thereto do not contain, and will not contain, any untrue statement
of a material fact and do not omit, and will not omit, to state a
material fact required to be stated therein or necessary to make
the statements therein not misleading. The Prospectus and any
amendments and supplements thereto do not contain, and will not
contain, any untrue statement of a material fact; and do not omit,
and will not omit, to state a material fact necessary in order to
make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that
the Company makes no representations or warranties as to
information contained in or omitted from the Registration Statement
or the Prospectus, or any such amendment or supplement, in reliance
upon, and in conformity with, written information furnished to the
Company by or on behalf of the Underwriter, specifically for use
therein, it being understood and agreed that the only such
information is that described in Section 12
herein.
(d)
Each Issuer Free Writing Prospectus,
as of its issue date and at all subsequent times through the
completion of the public offer and sale of the Shares or until any
earlier date that the Company notified or notifies the Underwriter
as described in the next sentence, did not, does not and will not
include any information that conflicted, conflicts or will conflict
with the information contained in the Registration Statement or the
Prospectus, including any document incorporated by reference
therein that has not been superseded or modified.
(e)
The Company has not, directly or
indirectly, distributed and will not distribute any offering
material in connection with the offering and sale of the Shares
other than any Preliminary Prospectus, the Prospectus and other
materials, if any, permitted under the Act and consistent with
Section 4(b)(i) below.
(f)
(i) At the time of filing the
Registration Statement and (ii) as of the date hereof (with
such date being used as the determination date for purposes of this
clause (ii)), the Company was not and is not an “ineligible
issuer” (as defined in Rule 405 under the Act, without
taking into account any determination by the Commission pursuant to
Rule 405 under the Act that it is not necessary that the
Company be considered an ineligible issuer), including, without
limitation, for purposes of Rules 164 and 433 under the Act
with respect to the offering of the Shares as contemplated by the
Registration Statement.
(g)
The Company has no significant
subsidiaries (as such term is defined in Rule 1-02 of
Regulation S-X promulgated by the Commission). The Company
owns, directly or indirectly, all of the capital stock of Dyax
Holdings B.V., Dyax B.V., and Dyax S.A. and all of the membership
interests of Dyax-Genzyme LLC (collectively, the “
Subsidiaries ”) free and clear of any lien, charge,
security interest, encumbrance, right of first refusal or other
restriction, and all the issued and outstanding shares of capital
stock of the Subsidiaries are validly issued
3
and are fully paid, nonassessable and free of
preemptive and similar rights. The Subsidiaries are the only
subsidiaries, direct or indirect, of the Company.
(h)
The consolidated financial
statements and the related notes thereto included or incorporated
by reference in the Registration Statement and the Prospectus or
the documents incorporated by reference therein comply with the
applicable requirements of the Act and the Exchange Act, as
applicable, and present fairly, the consolidated financial position
of the Company as of the dates indicated and its consolidated
results of operations and its consolidated cash flows for the
periods specified; such financial statements and the related notes
thereto have been prepared in conformity with generally accepted
accounting principles applied on a consistent basis throughout the
periods covered thereby (except as otherwise stated therein and
subject, in the case of unaudited financial statements, to the
absence of footnotes and normal year end adjustments) and all
adjustments necessary for a fair presentation of results for such
periods have been made, and the other financial information
included or incorporated by reference in the Registration Statement
and the Prospectus has been derived from the accounting records of
the Company and its Subsidiaries and presents fairly the
information shown thereby. No other consolidated financial
statements or schedules of the Company or any other entity (other
than Dyax-Genzyme LLC, which are so incorporated) are required by
the Act, the Rules and Regulations or the Exchange Act and the
rules promulgated thereunder to be included in the
Registration Statement or the Prospectus or the documents
incorporated therein by reference. The summary and selected
consolidated financial and statistical data included or
incorporated by reference in the Registration Statement, the
General Disclosure Package and the Prospectus presents fairly the
information shown therein and such data has been compiled on a
basis consistent with the financial statements presented therein
and the books and records of the Company (or Dyax-Genzyme LLC, as
applicable). All disclosures contained in the Registration
Statement, the General Disclosure Package and the Prospectus
regarding “non-GAAP financial measures” (as such term
is defined by the Rules and Regulations) comply with
Regulation G of the Exchange Act and Item 10 of Regulation S-K
under the Act, to the extent applicable. The Company and the
Subsidiaries do not have any material liabilities or obligations,
direct or contingent (including any off-balance sheet obligations
or any “variable interest entities” within the meaning
of Financial Accounting Standards Board Interpretation
No. 46), not disclosed in the Registration Statement, the
General Disclosure Package and the Prospectus.
(i)
Except as set forth in or otherwise
contemplated by the Registration Statement, the General Disclosure
Package or the Prospectus, since the date of the most recent
financial statements of the Company included or incorporated by
reference in the Registration Statement and the Prospectus and
prior to the Closing Date and the Option Closing Date, as the case
may be, (i) there has not been any change in the capital stock
of the Company (except for changes in the number of outstanding
shares of Common Stock of the Company due to the issuance of
shares, including without limitation shares issued under the
Company’s employee stock purchase plan, upon the exercise or
conversion of securities exercisable for, or convertible into,
shares of Common Stock outstanding on the date hereof) or long-term
debt of the Company or of its Subsidiaries or any dividend or
distribution of any kind declared, set aside for payment, paid or
made by the Company on any class of capital stock, or any material
adverse change, or any development that would reasonably be
expected to result in a material adverse change, in or affecting
the business, properties, management, consolidated financial
position, stockholders’ equity, or results of operations of
the Company and its Subsidiaries taken as a whole (a
4
“ Material Adverse Change ”);
(ii) neither the Company nor its Subsidiaries have entered
into any transaction or agreement, not in the ordinary course of
business, that is material to the Company and its Subsidiaries
taken as a whole or incurred or will incur any liability or
obligation, direct or contingent, not in the ordinary course of
business, that is material to the Company and its Subsidiaries
taken as a whole; and (iii) neither the Company nor its
Subsidiaries have sustained any material loss or interference with
its business from fire, explosion, flood or other calamity, whether
or not covered by insurance, or from any labor disturbance or
dispute or any action, order or decree of any court or arbitrator
or governmental or regulatory authority. The Company
and the Subsidiaries have no material contingent obligations which
are not disclosed in the Company’s financial statements
included in the Registration Statement, the General Disclosure
Package and the Prospectus.
(j)
Each of the Company and its
Subsidiaries is duly organized, validly existing as a corporation
and in good standing under the laws of their respective
jurisdictions of organization. The Company and its
Subsidiaries are duly licensed or qualified as a foreign
corporation for transaction of business and in good standing under
the laws of each other jurisdiction in which their respective
ownership or lease of property or the conduct of their respective
businesses requires such license or qualification, and have all
corporate power and authority necessary to own or hold their
respective properties and to conduct their respective businesses as
described in the Registration Statement, the General Disclosure
Package, and the Prospectus, except where the failure to be so
qualified or in good standing or have such power or authority would
not, individually or in the aggregate, have a material adverse
effect or would reasonably be expected to have a material adverse
effect on the business, properties, prospects, management,
consolidated financial position, stockholders’ equity or
results of operations of the Company and its Subsidiaries taken as
a whole (a “ Material Adverse Effect
”).
(k)
The issued and outstanding shares of
capital stock of the Company have been validly issued, are fully
paid and nonassessable and, other than as disclosed in or
contemplated by the Registration Statement, the General Disclosure
Package or the Prospectus, are not subject to any preemptive or
similar rights. The Company has an authorized, issued and
outstanding capitalization as set forth in the Registration
Statement and the Prospectus (and any similar section of
information contained in the General Disclosure Package) as of the
dates referred to therein (other than the grant of additional
options under the Company’s existing stock option plans, or
changes in the number of outstanding shares of Common Stock of the
Company due to the issuance of shares under the Company’s
employee stock purchase plan or upon the exercise or conversion of
securities exercisable for, or convertible into, shares of Common
Stock outstanding on the date hereof) and such authorized capital
stock conforms to the description thereof set forth in the
Registration Statement, the General Disclosure Package and the
Prospectus. The description of the securities of the Company
in the Registration Statement, the General Disclosure Package and
the Prospectus is complete and accurate in all material
respects. Except as disclosed in or contemplated by the
Registration Statement, the General Disclosure Package or the
Prospectus, as of the date referred to therein, the Company did not
have outstanding any options to purchase, or any rights or warrants
to subscribe for, or any securities or obligations convertible
into, or exchangeable for, or any contracts or commitments to issue
or sell, any shares of capital stock or other
securities.
5
(l)
The Company has full legal power and
authority to enter into this Agreement and to consummate the
transactions contemplated hereby. This Agreement has been duly
authorized, executed and delivered by the Company and constitutes a
legal, valid and binding obligation of the Company enforceable
against the Company in accordance with its terms except as rights
to indemnity and contribution thereunder may be limited by federal
or state securities laws and matters of public policy and except as
such enforceability may be subject to the effect of applicable
bankruptcy, insolvency, reorganization or similar laws affecting
creditors’ rights generally and equitable principles of
general applicability.
(m)
The Shares have been duly authorized
by the Company and, when issued and delivered and paid for as
provided herein, will be validly issued, fully paid and
nonassessable and will conform to the descriptions thereof in the
Registration Statement, the Prospectus and the General Disclosure
Package; and the issuance of the Shares is not subject to any
preemptive or similar rights that have not been
waived. The form of certificates for the Shares
conforms to the corporate law of the jurisdiction of the
Company’s incorporation.
(n)
Neither the Company nor its
Subsidiaries are (i) in violation of its charter or by-laws or
similar organizational documents; (ii) in default, and no
event has occurred that, with notice or lapse of time or both,
would constitute such a default, in the due performance or
observance of any term, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement or other
agreement or instrument to which the Company or its Subsidiaries
are a party or by which the Company or its Subsidiaries are bound
or to which any of the property or assets of the Company or its
Subsidiaries are subject; or (iii) in violation of any law or
statute or any judgment, order, rule or regulation of any
court or arbitrator or governmental or regulatory authority,
except, in the case of each of clauses (ii) and
(iii) above, for any such violation or default that would not,
individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.
(o)
The execution, delivery and
performance by the Company of this Agreement, the issuance and sale
by the Company of the Shares and the consummation by the Company of
the transactions contemplated by this Agreement will not
(i) conflict with or result in a breach or violation of any of
the terms or provisions of, or constitute a default under, or
result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company or its
Subsidiaries pursuant to, any indenture, mortgage, deed of trust,
loan agreement or other agreement or instrument to which the
Company or its Subsidiaries are a party or by which the Company or
its Subsidiaries are bound or to which any of the property or
assets of the Company or its Subsidiaries are subject;
(ii) result in any violation of the provisions of the charter
or by-laws or similar organizational documents of the Company or
its Subsidiaries; or (iii) result in the violation of any law
or statute or any judgment, order, rule or regulation of any
court or arbitrator or governmental or regulatory authority,
except, in the case of each of clauses (i) and
(iii) above, for any such conflict, breach, violation,
default, lien, charge or encumbrance that would not, individually
or in the aggregate, reasonably be expected to have a Material
Adverse Effect.
(p)
No consent, approval, authorization,
order, registration or qualification of or with any court or
arbitrator or governmental or regulatory authority is required for
the execution, delivery and performance by the Company of this
Agreement, the issuance and sale
6
by the Company of the Shares and the
consummation by the Company of the transactions contemplated by
this Agreement, except for the registration of the Shares under the
Act and such consents, approvals, authorizations, orders and
registrations or qualifications as may be required under applicable
state securities laws or by the by-laws and rules of the
Financial Industry Regulatory Authority (“ FINRA
”) in connection with the offering of the Shares by the
Underwriter.
(q)
There are no legal, governmental or
regulatory actions, suits or proceedings pending, nor, to the
Company’s knowledge, any legal, governmental or regulatory
investigations, to which the Company or its Subsidiaries are a
party or to which any property of the Company or its Subsidiaries
is the subject that, individually or in the aggregate, if
determined adversely to the Company or its Subsidiaries, would
reasonably be expected to have a Material Adverse Effect or
materially and adversely affect the ability of the Company to
perform its obligations contemplated hereby; to the Company’s
knowledge, no such actions, suits or proceedings are threatened or
contemplated by any governmental or regulatory authority or
threatened by others; and (i) there are no current or pending
legal, governmental or regulatory investigations, actions, suits or
proceedings that are required under the Act to be described in the
Registration Statement or the Prospectus or the documents
incorporated by reference therein that are not so described; and
(ii) there are no contracts or other documents that are
required under the Act to be filed as exhibits to the Registration
Statement or the documents incorporated by reference therein that
are not so filed.
(r)
PricewaterhouseCoopers LLP, who have
audited certain consolidated financial statements of the Company,
is an independent registered public accounting firm with respect to
the Company and the Subsidiaries within the meaning of the Act and
the applicable Rules and Regulations and the Public Company
Accounting Oversight Board (United States) (the “
PCAOB ”).
(s)
The Company and its Subsidiaries own
no real property. Except as disclosed in Notes 5 and 8 to the
Company’s consolidated financial statements for the year
ended December 31, 2008 that are incorporated by reference
into the Registration Statement, the Company and its Subsidiaries
have good and valid title to all personal property owned by them,
in each case free and clear of all liens, encumbrances and claims
except those that (i) do not materially interfere with the use
made and proposed to be made of such property by the Company and
its Subsidiaries or (ii) would not reasonably be expected,
individually or in the aggregate, to have a Material Adverse
Effect. Any real property leased by the Company and its
Subsidiaries is held by them under valid, existing and enforceable
leases, except those that (A) do not materially interfere with
the use made or proposed to be made of such property by the Company
or its Subsidiaries or (B) would not be reasonably expected,
individually or in the aggregate, to have a Material Adverse
Effect.
(t)
The Company and its Subsidiaries own
or possess adequate rights to use all patents, patent applications,
trademarks, service marks, trade names, trademark registrations,
service mark registrations, copyrights, licenses and know-how
(including trade secrets and other unpatented and/or unpatentable
proprietary or confidential information, systems or procedures)
(collectively, the “ Intellectual Property ”),
necessary for the conduct of their respective businesses as
conducted as of the date hereof, except to the extent that the
failure to own or
7
possess adequate rights to use such Intellectual
Property would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect; and the Company and its
Subsidiaries have not received any written notice of any claim of
infringement or conflict which asserted Intellectual Property
rights of others, which infringement or conflict, if the subject of
an unfavorable decision, would result in a Material Adverse
Effect.
(u)
No relationship, direct or indirect,
exists between or among the Company or its Subsidiaries, on the one
hand, and the directors, officers and stockholders of the Company,
on the other, which is required by the Act to be disclosed in the
Registration Statement and the Prospectus or the documents
incorporated by reference therein and is not so
disclosed.
(v)
The Company is not and, after giving
effect to the offering and sale of the Shares to be sold by the
Company and the application of the proceeds thereof as described in
the Prospectus, will not be an “investment company”
within the meaning of the Investment Company Act of 1940, as
amended, and the rules and regulations of the Commission
promulgated thereunder.
(w)
The Company and its Subsidiaries
have filed all federal, state, local and foreign tax returns (or
timely filed applicable extensions therefor) which have been
required to be filed and paid all taxes shown thereon through the
date hereof, to the extent that such taxes have become due and are
not being contested in good faith; and, except as otherwise
disclosed in or contemplated by the Registration Statement, the
General Disclosure Package or the Prospectus, no tax deficiency has
been determined adversely to the Company or its Subsidiaries which
has had, or would reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect. All tax
liabilities have been adequately provided for in the financial
statements of the Company, and the Company does not know of any
actual or proposed additional material tax assessments.
(x)
The Company and its Subsidiaries
possess or have obtained all licenses, certificates, permits and
other authorizations issued by, and have made all declarations and
filings with, the appropriate federal, state, local or foreign
governmental or regulatory authorities that are necessary for the
ownership or lease of their respective properties or the conduct of
their respective businesses as described in the Registration
Statement, the General Disclosure Package and the Prospectus (the
“ Permits ”), except where the failure to
possess, obtain or make the same would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect; and except as disclosed in or contemplated by the
Registration Statement, the General Disclosure Package or the
Prospectus, neither the Company nor its Subsidiaries have received
written notice of any proceeding relating to revocation or
modification of any such Permit or has any reason to believe that
such Permit will not be renewed in the ordinary course, except
where the failure to obtain any such renewal would not,
individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.
(y)
No labor disturbance by or dispute
with employees of the Company or its Subsidiaries exists or, to the
knowledge of the Company, is threatened which would reasonably be
expected to result in a Material Adverse Effect.
8
(z)
The Company and its Subsidiaries
(i) are in compliance with any and all applicable federal,
state, local and foreign laws, rules, regulations, decisions and
orders relating to the protection of human health and safety, the
environment or hazardous or toxic substances or wastes, pollutants
or contaminants (collectively, “ Environmental Laws
”); (ii) have received and are in compliance with all
permits, licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective
businesses as described in the Registration Statement, the General
Disclosure Package and the Prospectus; and (iii) have not
received notice of any actual or potential liability for the
investigation or remediation of any disposal or release of
hazardous or toxic substances or wastes, pollutants or
contaminants, except, in the case of any of clauses (i),
(ii) or (iii) above, for any such failure to comply or
failure to receive required permits, licenses, other approvals or
liability as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse
Effect.
(aa)
Each material employee benefit plan,
within the meaning of Section 3(3) of the Employee
Retirement Income Security Act of 1974, as amended (“
ERISA ”), that is maintained, administered or
contributed to by the Company or any of its affiliates for
employees or former employees of the Company and its Subsidiaries
has been maintained in material compliance with its terms and the
requirements of any applicable statutes, orders, rules and
regulations, including but not limited to ERISA and the Internal
Revenue Code of 1986, as amended (the “ Code ”);
no prohibited transaction, within the meaning of Section 406
of ERISA or Section 4975 of the Code, has occurred which would
result in a material liability to the Company with respect to any
such plan excluding transactions effected pursuant to a statutory
or administrative exemption; and for each such plan that is subject
to the funding rules of Section 412 of the Code or
Section 302 of ERISA, no “accumulated funding
deficiency” as defined in Section 412 of the Code has
been incurred, whether or not waived, and the fair market value of
the assets of each such plan (excluding for these purposes accrued
but unpaid contributions) exceeds the present value of all benefits
accrued under such plan determined using reasonable actuarial
assumptions.
(bb)
The Company has not, in the two
years preceding the date hereof, received any notice (written or
oral) from the Nasdaq Global Market, any stock exchange, market or
trading facility on which the Common Stock is or has been listed
(or on which it has been quoted) to the effect that the Company is
not in compliance with the listing or maintenance requirements of
such exchange, market or trading facility. The Company shall
comply in all material respects1 with all requirements of the
Nasdaq Global Market with respect to the issuance of Shares and
shall use its best efforts to have the Shares listed on the Nasdaq
Global Market on or before the Closing Date.
(cc)
There is and has been no failure on
the part of the Company, or to its knowledge after due inquiry, and
any of the Company’s directors or officers, in their
capacities as such, to comply with any applicable provisions of the
Sarbanes Oxley Act of 2002 and the rules and regulations
promulgated therewith (the “ Sarbanes Oxley Act
”). Each of the principal executive officer and the
principal financial officer of the Company (or each former
principal executive officer of the Company and each former
principal financial officer of the Company as applicable) has made
all certifications required by Sections 302 and 906 of the
Sarbanes-Oxley Act with respect to all reports, schedules, forms,
statements and other documents required to be filed by it with the
Commission. For purposes of the preceding sentence,
“principal executive
9
officer” and “principal financial
officer” shall have the meanings given to such terms in the
Sarbanes-Oxley Act. The Company has taken all necessary
actions to ensure that it is in compliance with all provisions of
the Sarbanes-Oxley Act that are in effect and with which the
Company is required to comply.
(dd)
The Company and its Subsidiaries
maintain systems of internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are
executed in accordance with management’s general or specific
authorizations; (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with
generally accepted accounting principles and to maintain asset
accountability; (iii) access to assets is permitted only in
accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets
is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences.
The Company has established disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the
Company and designed such disclosure controls and procedures to
ensure that material information relating to the Company and its
Subsidiaries is made known to the certifying officers by others
within those entities, particularly during the period in which the
Company’s Annual Report on Form 10-K or any Quarterly
Report on Form 10-Q, as the case may be, is being
prepared. The Company’s certifying officers have
evaluated the effectiveness of the Company’s controls and
procedures as of the end of the period covered by the
Form 10-K for the year ended December 31, 2008 (such
date, the “ Evaluation Date ”). The
Company presented in its Form 10-K for the year ended
December 31, 2008 the conclusions of the certifying officers
about the effectiveness of the disclosure controls and procedures
based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no significant changes in the
Company’s internal controls (as such term is defined in Item
307(b) of Regulation S-K under the Exchange Act) or, to the
Company’s knowledge, in other factors that could
significantly affect the Company’s internal controls.
Except as disclosed in the Registration Statement, the General
Disclosure Package and the Prospectus, neither the Company nor any
of the Subsidiaries is aware of (i) any material weakness in
its internal control over financial reporting or (ii) change
in internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the
Company’s internal control over financial
reporting.
(ee)
The operations of the Company and
its Subsidiaries are and have been conducted at all times in
material compliance with applicable financial record keeping and
reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of
all jurisdictions to which the Company or its Subsidiaries are
subject, the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered
or enforced by any governmental agency (collectively, the “
Money Laundering Laws ”) and no action, suit or
proceeding by or before any court or governmental agency, authority
or body or any arbitrator involving the Company or any of its
Subsidiaries with respect to the Money Laundering Laws is pending
or, to the best knowledge of the Company, threatened.
(ff)
There are no transactions,
arrangements and other relationships between and/or among the
Company, and/or, to the knowledge of the Company, any of its
affiliates and any unconsolidated entity, including, but not
limited to, any structural finance, special purpose or limited
purpose entity (each, an “ Off Balance Sheet
Transaction ”) that could reasonably be
10
expected to affect materially the
Company’s liquidity or the availability of or requirements
for its capital resources, including those Off Balance Sheet
Transactions described in the Commission’s Statement about
Management’s Discussion and Analysis of Financial Conditions
and Results of Operations (Release Nos. 33-8056; 34-45321; FR-61),
required to be described in the General Disclosure Package, the
Prospectus or the documents incorporated by reference therein which
have not been described as required.
(gg)
Neither the Company, nor any of its
Subsidiaries, nor, to the knowledge of the Company, any director,
officer, agent, employee or other person acting on behalf of the
Company or any of its Subsidiaries have, in the course of its
actions for, or on behalf of, the Company (i) used any
corporate funds for any unlawful contribution, gift, entertainment
or other unlawful expenses relating to political activity;
(ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate
funds; (iii) violated or is in violation of any provision of
the U.S. Foreign Corrupt Practices Act of 1977, as amended; or
(iv) made any unlawful bribe, rebate, payoff, influence
payment, kickback or other unlawful payment to any foreign or
domestic government official or employee.
(hh)
The Company and its Subsidiaries
carry, or are covered by, insurance in such amounts and covering
such risks as the Company and its Subsidiaries reasonably believe
are adequate for the conduct of their respective businesses as
described in the Registration Statement, the General Disclosure
Package and the Prospectus and the value of their properties and as
is customary for companies engaged in similar businesses in similar
industries.
(ii)
Neither the Company nor its
Subsidiaries are a party to any contract, agreement or
understanding with any person (other than this Agreement) that
would give rise to a valid claim against the Company or its
Subsidiaries or the Underwriter for a brokerage commission,
finder’s fee or like payment in connection with the offering
and sale of the Shares.
(jj)
No person has the right to require
the Company or its Subsidiaries to register any securities for sale
under the Act by reason of the filing of the Registration Statement
with the Commission or by reason of the issuance and sale of the
Shares, except for rights which have been waived.
(kk)
Neither the Company, nor to the
Company’s knowledge, any of its affiliates, has taken,
directly or indirectly, any action designed to cause or result in,
or which has constituted or which might reasonably be expected to
constitute, the stabilization or manipulation of the price of the
shares of Common Stock to facilitate the sale or resale of the
Shares. The Company acknowledges that the Underwriter
may engage in passive market making transactions in the Shares on
the Nasdaq Global Market in accordance with Regulation M under the
Exchange Act.
(ll)
No forward-looking statement (within
the meaning of Section 27A of the Act and Section 21E of
the Exchange Act) contained in the Registration Statement, the
General Disclosure Package or the Prospectus has been made or
reaffirmed without a reasonable basis or has been disclosed other
than in good faith.
(mm)
All contracts that are listed under
Part IV, Item 15(b) to the Company’s Annual Report
on Form 10-K for the year ended December 31, 2008 and
under Part II, Item 6 to
11
the Company’s Quarterly Report on
Form 10-Q for the quarter ended March 31, 2009, have been
duly authorized, executed and delivered by the Company, constitute
valid and binding agreements of the Company, and are enforceable
against the Company in accordance with the terms thereof, subject
to the effect of applicable bankruptcy, insolvency or similar laws
affecting creditors’ rights generally and equitable
principles of general applicability.
(nn)
No statement, representation or
warranty made in the certificate to be delivered to the Underwriter
pursuant to Section 6(f) below will be, when
made, inaccurate, untrue or incorrect in any material
respect.
(oo)
To enable the Underwriter to rely on
Rule 5110(b)(7)(C)(i) of FINRA, the Company represents
that it (i) has a non-affiliate, public common equity float of
at least $150 million or a non-affiliate, public common equity
float of at least $100 million and annual trading volume of at
least three million shares and (ii) has been subject to the
Exchange Act reporting requirements for a period of at least 36
months.
2.
Purchase, Sale and Delivery of
the Shares .
(